;

Statistics for Bergenbio ASA (id:10486 BGBIO)


Valuation metrics

Market cap
490.15M
Enterprise value
39.80M
Trailing P/E (ttm)
3.00
Forward P/E
-2.15
PEG ratio
-2.15
Price/Sales (ttm)
940.79
Price/Book (mrq)
2.65
Enterprise Value/Revenue
76.39
Enterprise Value/EBITDA
3.00

Overview

Shares outstanding
39.09M
Float
23.24M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
1.05M
Average volume (90 days)

Price summary

52-Week low
5.62
52-Week high
35.80
52-Week change
-232.74%
Beta
1.64
50-Day moving average
8.98
200-Day moving average
12.74

Dividends and splits

Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
May 30, 2024

Financials

Fiscal year
Fiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
-31,123.80%
Operational effectiveness
Return on assets
-44.17%
Return on equity
-85.55%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-161,940,000.00
Net income to common (ttm)
-155,404,992.00
Diluted EPS (ttm)
-1.74
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
200.12M
Total cash per share (mrq)
5.12
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
505.10%
Book value per share (mrq)
4.74
Cash flow
Cash flow statement
-175,687,008.00
Levered free cash flow (LFCF)
-108,987,872.00

CleverShares.com|
2024 ©

1.0.9119.29486